Related Experiment Videos

Rapid progressive hepatitis C after liver transplantation: a case report

T Takeishi1, Y Sato, T Ichida

  • 1Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. tochiogou@yahoo.co.jp

Transplantation Proceedings
|November 25, 2004
PubMed

Insights

Hepatitis C rapidly recurred after a liver transplant in a patient on hemodialysis. Immunosuppression from hemodialysis and splenectomy likely contributed to the aggressive Hepatitis C virus (HCV) recurrence post-transplant.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Virology

Background:

  • Hepatocellular carcinoma (HCC) in patients with liver cirrhosis often necessitates liver transplantation.
  • Living-related donor liver transplantation (LRDLT) is a viable option for end-stage liver disease.
  • Hepatitis C virus (HCV) recurrence post-transplantation is a significant clinical challenge.

Observation:

  • A 56-year-old male with chronic renal failure on hemodialysis underwent LRDLT and splenectomy for liver cirrhosis (HCV genotype 1b) with HCC.
  • Postoperative day 69, the patient developed fever and elevated liver enzymes, indicating liver dysfunction.
  • Liver biopsy confirmed rapid recurrence of progressive Hepatitis C infection.

Findings:

  • Treatment with Interferon beta (IFNβ) normalized liver function.
  • HCV-RNA levels decreased significantly post-treatment, indicating viral load reduction.
  • The patient's immunosuppression, potentially exacerbated by hemodialysis and splenectomy, was inferred as the cause of rapid HCV recurrence.

Implications:

  • Hemodialysis and splenectomy may increase the risk of aggressive HCV recurrence after LRDLT.
  • Early diagnosis and prompt antiviral therapy are crucial for managing post-transplant HCV recurrence.
  • Further research is needed to understand the interplay between immunosuppression, renal failure, and HCV recurrence in liver transplant recipients.